EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi

Ozge Hurdogan, Can Baykal, İsmail Yilmaz, Begum Yeni Erdem, Nesimi Buyukbabani, Sule Ozturk Sari iD

Journal of Cutaneous Pathology · 2026

DOI: 10.1111/cup.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2026. Verfasst von Ozge Hurdogan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Melanoma, Nevus, Pigmented, Skin Neoplasms, Antigens, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malignant melanoma (MM) and proliferative nodules (PN) may arise in large/giant congenital melanocytic nevi (LCMN/GCMN), posing clinical and pathological challenges in differential diagnosis. We investigated immunohistochemical expression of PRAME and H3K27me3 in MMs and PNs in LCMN/GCMN, examining their potential utility.

Methods

Three MMs and six PNs arising in LCMN/GCMN were subjected to immunohistochemical analyses. PRAME staining was scored as percentage of positive cells and H3K27me3 as follows: score0 = no staining; score1 = 1%–25%; score2 = 26%–50%; score3 = 51%–75%; score4 = 76%–100% staining in tumor cells. BRAF , NRAS , KIT , GNAQ, GNA11 , and TERT mutations were tested by polymerase chain reaction‐based direct Sanger sequencing for 3 MMs.

Results

Mean age was 6.2 (0–24), 33.6% were male. All MM cases were metastatic and two died of disease. CMN components were negative for PRAME in all cases, whereas 3 MMs and 1 PN were positive (> 90%). MMs showed loss of H3K27me3 expression, whereas expression was retained in all PNs. Two cases showed NRAS mutations in both MM and nevus components.

Conclusion

Combined use of PRAME and H3K27me3 can be utilized to discriminate MM from PN arising in LCMN/GCMN if validated on larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNevus, PigmentedSkin NeoplasmsAntigens, NeoplasmBiomarkers, TumorHistonesHumansMaleFemaleDiagnosis, DifferentialChildChild, PreschoolInfantAdolescentYoung AdultCutaneous Malignant MelanomaImmunohistochemistryInfant, Newborn

Stichwörter der Autor:innen

H3K27me3PRAMEcongenital melanocytic nevusmalignant melanomaproliferative nodule

Substanzen

PRAME protein, humanAntigens, NeoplasmBiomarkers, TumorHistones

Autor:innen und Institutionen

  • Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Department of Dermatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Department of Pathology, University of Health Sciences, Sultan 2. Abdul Hamid Khan Educational and Research Hospital, Istanbul, Turkey.
  • Department of Pathology, Koc University Hospital, Istanbul, Turkey.

ORCID-Profile: Sule Ozturk Sari

Zitieren

APA

Hurdogan, O., Baykal, C., Yilmaz, İ., Erdem, B. Y., Buyukbabani, N., & Sari, S. O. (2026). Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.70119

Vancouver

Hurdogan O, Baykal C, Yilmaz İ, Erdem BY, Buyukbabani N, Sari SO. Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi. Journal of Cutaneous Pathology. 2026. doi:10.1111/cup.70119

BibTeX
@article{Hurdogan2026,
  author = {Hurdogan, Ozge and Baykal, Can and Yilmaz, İsmail and Erdem, Begum Yeni and Buyukbabani, Nesimi and Sari, Sule Ozturk},
  title = {Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi},
  journal = {Journal of Cutaneous Pathology},
  year = {2026},
  doi = {10.1111/cup.70119}
}
Kostenlos starten →